Access to medication for prevention and treatment of COVID-19 in pharmacy

Medication used in for prevention and treatment of COVID-19 will now be distributed in Québec pharmacies.
If you are experiencing symptoms of COVID-19, please do not come to the pharmacy.

*This page contains information from the Gouvernement du Québec. Please consult the Gouvernement’s website (in French) for the most recent information on that topic.

What medications are available?

There is a treatment for COVID-19, called PaxlovidTM, to be taken if symptoms have developed for less than five days and a positive COVID-19 test is obtained. This treatment is prescribed to certain types of more vulnerable populations who could benefit from it to prevent complications of the disease.

A preventive treatment (pre-exposure prophylaxis), called EvusheldTM, is available for patients who are not currently infected with COVID-19 and who have had no known recent contact with a person infected with COVID-19. This drug may be prescribed for immunocompromised individuals who are unlikely to have an adequate response to vaccination, or for individuals for whom vaccination against COVID-19 is not recommended. It is intended to provide enhanced immunity to the virus. 

For more information, you can consult the Gouvernement du Québec pages on this subject:

How to get it?

If you are experiencing symptoms of COVID-19, please do not come to the pharmacy. We invite you to contact your pharmacist by phone for a consultation. If they consider that the COVID-19 treatment is right for you, they can prescribe it and have it delivered to your home.

If you have no symptoms of COVID-19 and would like to know more about the COVID-19 preventive medication, do not hesitate to visit your pharmacist for a consultation. If they feel that the treatment is right for you, they can prescribe it for you.

If you have any questions, ask your pharmacist.

An important message from your Brunet affiliated pharmacist-owner. Certain conditions apply.

Important notes

These medications offer more tools for the therapeutic array that could reduce the risks of complications among vulnerable patients.

×

Send to a friend

From:
To:
×
Pick up location

You may change the store at any time.

Please click on Search to display the results.
×
Store change

Loading...